SCHEMBL3767547

SCHEMBL3767547

CCCCCCCCCCCCCCCC/C=C/OC(=O)C(O)CO

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.51
FAAH O00519 3/20 0.49
PRKCA P17252 2/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCD Q05655 1/20 0.46
MAPT P10636 5/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
CYP2D6 P10635 3/20 0.44
MAPK1 P28482 3/20 0.44
TP53 P04637 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
GMNN O75496 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18662306 1.00 DGKA (0.51) DGKAFAAHPRKCAPRKCEPRKCQ
SCHEMBL16673480 1.00 DGKA (0.51) DGKAFAAHPRKCAPRKCEPRKCQ
SCHEMBL5482400 1.00 DGKA (0.51) DGKAFAAHPRKCAPRKCEPRKCQ
SCHEMBL27891886 0.89 DGKA (0.46) DGKAFAAHALDH1A1
SCHEMBL7094782 0.84 DGKA (0.41) DGKAFAAHPRKCAPRKCEPRKCQ
SCHEMBL3019481 0.83 DGKA (0.47) DGKAFAAHALDH1A1HPGDLMNA
SCHEMBL3019478 0.83 DGKA (0.47) DGKAFAAHALDH1A1HPGDLMNA
SCHEMBL27508207 0.83 DGKA (0.47) DGKAFAAHALDH1A1HPGDLMNA
SCHEMBL407730 0.81 DGKA (0.55) DGKAFAAHPRKCAPRKCEPRKCQ
SCHEMBL1768207 0.81 DGKA (0.55) DGKAFAAHPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210322289-A1 SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS Schülke & Mayr GmbH (DE) 2021-10-21 US disclosed
EP-3849501-A1 SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS SCHÜLKE & MAYR GmbH (DE) 2021-07-21 EP disclosed
WO-2020043372-A1 SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS Schülke & Mayr GmbH (DE) 2020-03-05 WO disclosed
US-8728998-B2 Glyceryl ethers as preservatives for cooling lubricants AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2014-05-20 US disclosed
US-7846885-B2 Glyceryl ethers as preservatives for cooling lubricants AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2010-12-07 US disclosed
US-20080171679-A1 GLYCERYL ETHERS AS PRESERVATIVES FOR COOLING LUBRICANTS AIR LIQUIDE, SANTE (FR) 2008-07-17 US disclosed
US-7268102-B2 Glyceryl ethers as preservatives for cooling lubricants AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2007-09-11 US disclosed
US-20070197414-A1 Glyceryl ethers as preservatives for cooling lubricants AIR LIQUIDE, SANTE (INTERNATIONAL) (FR) 2007-08-23 US disclosed
US-20070108405-A1 Compositions and methods for delivery of biologically active agents FH FAULDING & CO., LTD. (AU) 2007-05-17 US disclosed
EP-1667656-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS FH Faulding & Co. Limited (AU) 2006-06-14 EP disclosed
WO-2005021046-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS FH FAULDING & CO LTD (AU) 2005-03-10 WO disclosed
US-20030232729-A1 Glyceryl ethers as preservatives for cooling lubricants AIR LIQUIDE, SANTE (INTERNATIONAL) (FR) 2003-12-18 US disclosed
EP-1369471-A1 Glyceryl ethers as preservatives for cooling lubricants Air Liquide Santé (International) (FR) 2003-12-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210322289-A1 SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS MGLL, ADH5, GK DGKA 46/4885FAAH 55/4885PRKCA 3722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.